Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal

Neuroscience

Volumn 281, Issue , 2014, Pages 35-43

  Tu, W ^a   Cook, A ^a   Scholl, J L ^a   Mears, M ^a   Watt, M J ^a   Renner, K J ^b   Forster, G L ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Anxiety; Hippocampus; Psychostimulant; Rat; Serotonin; Withdrawal

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; AMPHETAMINE; DOPAMINE; MONOAMINE; NORADRENALIN; PAROXETINE; SEROTONIN; CENTRAL STIMULANT AGENT; SEROTONIN RECEPTOR AFFECTING AGENT;

ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG WITHDRAWAL; ELEVATED PLUS MAZE TEST; HIPPOCAMPUS; HISTOLOGY; MALE; NONHUMAN; RAT; STEREOTAXIC SURGERY; VENTRAL HIPPOCAMPUS; AMPHETAMINE DEPENDENCE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PREVENTION AND CONTROL; SPRAGUE DAWLEY RAT; WITHDRAWAL SYNDROME;

5,7-DIHYDROXYTRYPTAMINE; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANXIETY; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84908077865     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.09.019     Document Type: Article

References (48)

1. Baganz N., Horton R., Martin K., Holmes A., Daws L.C. Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci 2010, 30:15185-15195.
2. Baganz N.L., Horton R.E., Calderon A.S., Owens W.A., Munn J.L., Watts L.T., Koldzic-Zivanovic N., Jeske N.A., Koek W., Toney G.M., Daws L.C. Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci USA 2008, 105:18976-18981.
3. Barr J.L., Forster G.L. Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment. Neuroscience 2011, 182:105-114.
4. Barr J.L., Renner K.J., Forster G.L. Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus. Neuropharmacology 2010, 59:395-405.
5. Barr J.L., Scholl J.L., Solanki R.R., Watt M.J., Lowry C.A., Renner K.J., Forster G.L. Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus. Eur J Neurosci 2013, 37:479-490.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
7. Cantwell B., McBride A.J. Self detoxication by amphetamine dependent patients: a pilot study. Drug Alcohol Depend 1998, 49:157-163.
8. Carli M., Tatarczynska E., Cervo L., Samanin R. Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur J Pharmacol 1993, 234:215-221.
9. Chao H.M., Choo P.H., McEwen B.S. Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain. Neuroendocrinology 1989, 50:365-371.
10. Daws L.C. Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 2009, 121:89-99.
11. De Kloet R., Wallach G., McEwen B.S. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 1975, 96:598-609.
12. Fuss J., Vogt M.A., Weber K.J., Burke T.F., Gass P., Hensler J.G. Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-term voluntary wheel running. Synapse 2013, 67:648-655.
13. Gossop M. Review: limited evidence to support pharmacological therapy for amphetamine withdrawal. Evid-Based Mental Health 2009, 12:122.
14. Graeff F.G., Guimaraes F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 1996, 54:129-141.
15. Grundemann D., Schechinger B., Rappold G.A., Schomig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1998, 1:349-351.
16. Guimaraes F.S., Del Bel E.A., Padovan C.M., Netto S.M., de Almeida R.T. Hippocampal 5-HT receptors and consolidation of stressful memories. Behav Brain Res 1993, 58:133-139.
17. Gutierrez-Castellanos N., Pardo-Bellver C., Martinez-Garcia F., Lanuza E. The vomeronasal cortex - afferent and efferent projections of the posteromedial cortical nucleus of the amygdala in mice. Eur J Neurosci 2014, 39:141-158.
18. Hensler J.G. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 2003, 72:1665-1682.
19. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. Off Publ Am Coll Neuropsychopharmacol 2000, 23:477-501.
20. Joca S.R., Ferreira F.R., Guimaraes F.S. Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems. Stress 2007, 10:227-249.
21. Jonsson G. Chemical neurotoxins as denervation tools in neurobiology. Annu Rev Neurosci 1980, 3:169-187.
22. Kataoka Y., Shibata K., Miyazaki A., Inoue Y., Tominaga K., Koizumi S., Ueki S., Niwa M. Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic. Neuropharmacology 1991, 30:475-480.
23. Keck M.E., Sartori S.B., Welt T., Muller M.B., Ohl F., Holsboer F., Landgraf R., Singewald N. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem 2005, 92:1170-1179.
24. Kia H.K., Miquel M.C., Brisorgueil M.J., Daval G., Riad M., El Mestikawy S., Hamon M., Verge D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol 1996, 365:289-305.
25. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharmaceut Res 2007, 24:1227-1251.
26. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 2000, 909:170-185.
27. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol 2003, 13:442-452.
28. Kusljic S., van den Buuse M. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. Eur J Neurosci 2004, 20:3424-3432.
29. Kusserow H., Davies B., Hortnagl H., Voigt I., Stroh T., Bert B., Deng D.R., Fink H., Veh R.W., Theuring F. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin1A receptors. Brain Res 2004, 129:104-116.
30. Li H., Scholl J.L., Tu W., Hassell J., Watt M.J., Forster G.L., Renner K.J. Stress-induced limbic serotonergic responses are altered during withdrawal from amphetamine. Eur J Neurosci 2014, [in press]. 10.1111/ejn12735.
31. Ling T.J., Forster G.L., Watt M.J., Korzan W.J., Renner K.J., Summers C.H. Social status differentiates rapid neuroendocrine responses to restraint stress. Physiol Behav 2009, 96:218-232.
32. Lowry C.A., Burke K.A., Renner K.J., Moore F.L., Orchinik M. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm Behav 2001, 39:195-205.
33. Maras P.M., Petrulis A. The posteromedial cortical amygdala regulates copulatory behavior, but not sexual odor preference, in the male Syrian hamster (Mesocricetus auratus). Neuroscience 2008, 156:425-435.
34. Markstein R., Hoyer D., Engel G. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn Schmiedeberg's Arch Pharmacol 1986, 333:335-341.
35. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 2003, 70:83-244.
36. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic Press, San Diego.
37. Renner K., Luine V. Analysis of temporal and dose-dependent effects of estrogen on monoamines in brain nuclei. Brain Res 1986, 366:64-71.
38. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
39. Romanelli F., Smith K.M. Clinical effects and management of methamphetamine abuse. Pharmacotherapy 2006, 26:1148-1156.
40. Schuckit M.A., Daeppen J.B., Danko G.P., Tripp M.L., Smith T.L., Li T.K., Hesselbrock V.M., Bucholz K.K. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. Am J Psychiatry 1999, 156:41-49.
41. Shoptaw S.J., Kao U., Heinzerling K., Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2009, CD003021. [online].
42. Srisurapanont M., Arunpongpaisal S., Wada K., Marsden J., Ali R., Kongsakon R. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis. Prog Neuro-psychopharmacol Biol Psychiatry 2011, 35:959-964.
43. Srisurapanont M., Jarusuraisin N., Jittiwutikan J. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Aust N Z J Psychiatry 1999, 33:89-93.
44. Srisurapanont M., Jarusuraisin N., Jittiwutikan J. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment. Aust N Z J Psychiatry 1999, 33:94-98.
45. Stefanski R., Palejko W., Bidzinski A., Kostowski W., Plaznik A. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists. Neuropharmacology 1993, 32:977-985.
46. Vuong S.M., Oliver H.A., Scholl J.L., Oliver K.M., Forster G.L. Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behav Brain Res 2010, 208:278-281.
47. Watt M.J., Forster G.L., Korzan W.J., Renner K.J., Summers C.H. Rapid neuroendocrine responses evoked at the onset of social challenge. Physiol Behav 2007, 90:567-575.
48. Wright I.K., Upton N., Marsden C.A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology 1992, 109:338-346.